Sandbox GGC16: Difference between revisions
From Proteopedia
Jump to navigationJump to search
No edit summary |
No edit summary |
||
| Line 1: | Line 1: | ||
==PU.1== | ==PU.1== | ||
<StructureSection load='1PUE' size='340' side='right' caption='Caption for this structure' scene=''> | <StructureSection load='1PUE' size='340' side='right' caption='Caption for this structure' scene=''> | ||
PU.1 is a hematopoietic transcription factor. It specifically regulates transcription of | PU.1 is a hematopoietic transcription factor. It specifically regulates transcription of genes specific to myeloid and lymphoid cells, ultimately leading to cellular differentiation. | ||
== Name == | == Name and Location == | ||
The name PU.1 comes from the protein's binding interactions with a purine-rich DNA sequence. | The name PU.1 comes from the protein's binding interactions with a purine-rich DNA sequence. | ||
<scene name='87/874948/Earpurinerich/2'>Bases at Interface</scene> | <scene name='87/874948/Earpurinerich/2'>Bases at Interface</scene> | ||
The protein resides in the nucleus. | |||
===Binding Domain=== | ===Binding Domain=== | ||
<scene name='87/874948/ | <scene name='87/874948/Earbindingresiduesbest/1'>Residues at Binding Domain</scene> | ||
Ets binding domain is conserved across the Ets family of proteins. | |||
Binding domain is positively charged. Residues most closely interacting with DNA include Arginine and Lysine. | |||
== Disease == | == Disease == | ||
PU.1 has been identified as an oncogene. Mutations have been identified in patients with leukemias and lymphomas. Interestingly, the mutations are not always identified within the binding site. | |||
== PEST domain == | |||
== Structural highlights == | == Structural highlights == | ||
Revision as of 15:44, 24 April 2021
PU.1
| ||||||||||||